teva pharmaceuticals introduces the first generic glp-1 for weight loss Diabetes patients now have access to medication: ‘More accessible and affordable’ Generic Liraglutide (Victoza) Becomes First
Description
2017;26:620632 e626
GLP-1 receptor agonists can be valuable tools for managing diabetes and weight in patients with Hashimoto's disease when used appropriately and with proper monitoring
C., Pinto, A
These results are echoed through meta-analyses
Switching may be possible, but should only be done under the supervision of a qualified healthcare provider
Ozempic Highlights of Prescribing Information
